TY - STD TI - AllTrials Campaign. [http://www.alltrials.net]. Accessed 11 April 2016. UR - http://www.alltrials.net/ ID - ref1 ER - TY - STD TI - British Medical Journal Open Data Campaign. [http://www.bmj.com/open-data]. Accessed 11 April 2016. UR - http://www.bmj.com/open-data ID - ref2 ER - TY - STD TI - European Medicines Agency. European Medicines Agency Draft policy on publication and access to clinical-trial data. 24 June 2013 [http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/06/WC500144730.pdf] Accessed 11 April 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/06/WC500144730.pdf ID - ref3 ER - TY - STD TI - European Federation of Pharmaceutical Industries and Associations (EFPIA) and Pharmaceutical Research and Manufacturers of America (PhRMA). Principles for responsible clinical trial data sharing: our commitment to patients and researchers. 18 July 2013. [http://www.phrma.org/sites/default/files/pdf/PhRMAPrinciplesForResponsibleClinicalTrialDataSharing.pdf]. Accessed 11 April 2016. UR - http://www.phrma.org/sites/default/files/pdf/PhRMAPrinciplesForResponsibleClinicalTrialDataSharing.pdf ID - ref4 ER - TY - STD TI - European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use. 2 Oct 2014. [http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/10/WC500174796.pdf]. Accessed 11 April 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/10/WC500174796.pdf ID - ref5 ER - TY - JOUR AU - Fletcher, C. AU - Driessen, S. AU - Burger, H. U. AU - Gerlinger, C. AU - Biesheuvel, E. PY - 2013 DA - 2013// TI - European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data JO - Pharm Stat VL - 12 UR - https://doi.org/10.1002/pst.1603 DO - 10.1002/pst.1603 ID - Fletcher2013 ER - TY - STD TI - European Federation of Pharmaceutical Industries and Associations. Clinical Trial Data Portal Gateway [http://transparency.efpia.eu/responsible-data-sharing/efpia-clinical-trial-data-portal-gateway]. Accessed 13 April 2016. UR - http://transparency.efpia.eu/responsible-data-sharing/efpia-clinical-trial-data-portal-gateway ID - ref7 ER - TY - BOOK PY - 2015 DA - 2015// TI - Sharing clinical trial data: maximizing benefits, minimizing risk PB - The National Academies Press CY - Washington, DC ID - ref8 ER - TY - STD TI - Varnai P, Rentel MC, Simmonds P, Sharp TA, Mostert B, de Jongh T. Assessing the research potential of access to Clinical Trial Data. Report to Wellcome Trust 2015 [http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_peda/documents/web_document/WTP058912.pdf]. Accessed 13 April 2016. UR - http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_peda/documents/web_document/WTP058912.pdf ID - ref9 ER - TY - STD TI - MRCT Center of Harvard and Brigham and Women’s Hospital. Proceedings of Promoting Clinical Trial Data Transparency Conference. March 2015 [http://mrctcenter.org/wp-content/uploads/2015/11/2015-04-30_mrct_data_transparency_conf_proceedings.pdf]. Accessed 13 April 2016. UR - http://mrctcenter.org/wp-content/uploads/2015/11/2015-04-30_mrct_data_transparency_conf_proceedings.pdf ID - ref10 ER - TY - STD TI - Tudur Smith C, Hopkins C, Sydes M, Woolfall K, Clarke M, Murray G, Williamson P. Good Practice Principles for Sharing Individual Participant Data from Publicly Funded Clinical Trials. Version 1, Apr 2015. [http://www.methodologyhubs.mrc.ac.uk/files/7114/3682/3831/Datasharingguidance2015.pdf] Accessed 13 April 2016. UR - http://www.methodologyhubs.mrc.ac.uk/files/7114/3682/3831/Datasharingguidance2015.pdf ID - ref11 ER - TY - STD TI - European Medicines Agency. External guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use. 2 March 2016. [http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2016/03/WC500202621.pdf] Accessed 11 March 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2016/03/WC500202621.pdf ID - ref12 ER - TY - STD TI - US Office for Civil Rights (OCR). Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. 26 Nov 2012. [http://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/De-identification/hhs_deid_guidance.pdf] Accessed 11 March 2016. UR - http://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/De-identification/hhs_deid_guidance.pdf ID - ref13 ER - TY - JOUR AU - Doshi, P. AU - Jefferson, T. PY - 2013 DA - 2013// TI - Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports JO - BMJ Open VL - 3 UR - https://doi.org/10.1136/bmjopen-2012-002496 DO - 10.1136/bmjopen-2012-002496 ID - Doshi2013 ER - TY - STD TI - Higgins JPT, Green S. (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. [http://handbook.cochrane.org/]. Accessed 13 April 2016. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196245/] UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196245/ ID - ref15 ER - TY - STD TI - ClinicalTrials.gov [https://clinicaltrials.gov/] Accessed 13 April 2016. UR - https://clinicaltrials.gov/ ID - ref16 ER - TY - STD TI - EUdraCT public website [https://eudract.ema.europa.eu/index.html] Accessed 13 April 2016. UR - https://eudract.ema.europa.eu/index.html ID - ref17 ER - TY - STD TI - WHO International Clinical Trials Registry Platform [http://www.who.int/ictrp/en/] Accessed 13 April 2016. UR - http://www.who.int/ictrp/en/ ID - ref18 ER - TY - JOUR AU - Anderson, M. AU - Chiswell, K. AU - Peterson, E. AU - Tasneem, A. AU - Topping, M. AU - Califf, R. PY - 2015 DA - 2015// TI - Compliance with Results Reporting at ClinicalTrials.gov JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMsa1409364 DO - 10.1056/NEJMsa1409364 ID - Anderson2015 ER - TY - JOUR AU - Miller, J. E. AU - Korn, D. AU - Ross, J. S. PY - 2015 DA - 2015// TI - Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012 JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2015-009758 DO - 10.1136/bmjopen-2015-009758 ID - Miller2015 ER - TY - STD TI - FDA Approved Drug Products [http://www.accessdata.fda.gov/scripts/cder/drugsatfda/] Accessed 13 April 2016. UR - http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ ID - ref21 ER - TY - STD TI - European Medicines Agency. European Public Assessment Reports. [http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124]. Accessed 11 April 2016. UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124 ID - ref22 ER - TY - STD TI - GSK Press Release 22 April 2014 [http://us.gsk.com/en-us/media/press-releases/2014/gsk-announces-major-3-part-transaction-with-novartis-to-drive-sustainable-sales-growth-improve-long-term-earnings-and-deliver-increasing-returns-to-shareholders/]. Accessed 13 April 2016. UR - http://us.gsk.com/en-us/media/press-releases/2014/gsk-announces-major-3-part-transaction-with-novartis-to-drive-sustainable-sales-growth-improve-long-term-earnings-and-deliver-increasing-returns-to-shareholders/ ID - ref23 ER - TY - JOUR AU - Krumholz, H. AU - Gross, C. AU - Blount, K. AU - Ritchie, J. AU - Hodshon, B. AU - Lehman, R. AU - Ross, J. PY - 2014 DA - 2014// TI - Sea change in open science and data sharing: leadership by industry JO - Circ Cardiovasc Qual Outcomes VL - 7 UR - https://doi.org/10.1161/CIRCOUTCOMES.114.001166 DO - 10.1161/CIRCOUTCOMES.114.001166 ID - Krumholz2014 ER - TY - JOUR AU - Conroy, E. AU - Harman, N. AU - Lane, J. AU - Lewis, S. AU - Murray, G. AU - Norrie, J. AU - Sydes, M. AU - Gamble, C. PY - 2015 DA - 2015// TI - Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences JO - Clin Trials VL - 12 UR - https://doi.org/10.1177/1740774515589959 DO - 10.1177/1740774515589959 ID - Conroy2015 ER - TY - STD TI - Clinical Study Data Request.com. [https://www.clinicalstudydatarequest.com/]. Accessed 13 April 2016. UR - https://www.clinicalstudydatarequest.com/ ID - ref26 ER - TY - STD TI - Pfizer. Data Access Requests. [http://www.pfizer.com/research/clinical_trials/trial_data_and_results/data_requests]. Accessed 13 April 2016. UR - http://www.pfizer.com/research/clinical_trials/trial_data_and_results/data_requests ID - ref27 ER - TY - STD TI - The Yale University Open Data Access (YODA) Project. [http://yoda.yale.edu/]. Accessed 13 April 2016. UR - http://yoda.yale.edu/ ID - ref28 ER - TY - STD TI - Cochrane Collaboration. Standards for the reporting of Plain Language Summaries in new Cochrane Intervention Reviews (PLEACS) Version 3.0 [http://editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/PLEACS_0.pdf]. Accessed 13 April 2016. UR - http://editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/PLEACS_0.pdf ID - ref29 ER - TY - STD TI - MRCT Center of Harvard and Brigham and Women’s Hospital. Return of aggregate results. [http://mrctcenter.org/return-results]. Accessed 13 April 2016. UR - http://mrctcenter.org/return-results ID - ref30 ER - TY - STD TI - British Library. Writing about biomedical and health research in plain English: A guide for authors. [http://www.access2understanding.org/wp-content/uploads/2014/11/Access-to-Understanding-writing-guidance_v1.pdf] Accessed 11 April 2016. UR - http://www.access2understanding.org/wp-content/uploads/2014/11/Access-to-Understanding-writing-guidance_v1.pdf ID - ref31 ER - TY - STD TI - Amgen. Clinical Trial Transparency, Data Sharing and Disclosure Practices. [http://www.amgen.com/about/data_sharing.html]. Accessed 15 April 2016. UR - http://www.amgen.com/about/data_sharing.html ID - ref32 ER - TY - STD TI - Pfizer. Transparency of clinical trial data. [http://www.pfizer.co.uk/content/transparency-clinical-trial-data] Accessed 15 April 2016. UR - http://www.pfizer.co.uk/content/transparency-clinical-trial-data ID - ref33 ER - TY - STD TI - ICH E9 Expert Working Group. Statistical principles for clinical trials: ICH harmonized tripartite guideline. Stat Med. 1999;18(15):1905–42. [doi: 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.0.CO;2-F] [http://www.ncbi.nlm.nih.gov/pubmed/10532877] UR - http://www.ncbi.nlm.nih.gov/pubmed/10532877 ID - ref34 ER - TY - STD TI - The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Guide on methodological standards in pharmacoepidemiology (Revision 4). EMA/95098/2010. [http://www.encepp.eu/standards_and_guidances/documents/ENCePPGuideofMethStandardsinPE_Rev4.pdf] Accessed 15 April 2016. UR - http://www.encepp.eu/standards_and_guidances/documents/ENCePPGuideofMethStandardsinPE_Rev4.pdf ID - ref35 ER - TY - STD TI - Immune Tolerance Network. TrialShare. [http://www.immunetolerance.org/node/1121]. Accessed 15 April 2016. UR - http://www.immunetolerance.org/node/1121 ID - ref36 ER - TY - STD TI - Alzheimer’s Disease Neuroimaging Initiative (ADNI). Sharing Alzheimer's research data with the world. [http://adni.loni.usc.edu/] Accessed 15 April 2016. UR - http://adni.loni.usc.edu/ ID - ref37 ER - TY - STD TI - AstraZeneca Group of Companies. Data request portal. [https://astrazenecagroup-dt.pharmacm.com/DT/Home]. Accessed 15 April 2016. UR - https://astrazenecagroup-dt.pharmacm.com/DT/Home ID - ref38 ER - TY - STD TI - Merck. Company procedure on access to clinical trial data. [http://www.merck.com/clinical-trials/pdf/Procedure_on_access_to_clinical_trial_data_2016.pdf]. Accessed 15 April 2016. UR - http://www.merck.com/clinical-trials/pdf/Procedure_on_access_to_clinical_trial_data_2016.pdf ID - ref39 ER - TY - STD TI - Shire. Our commitment to transparency. [http://www.shiretrials.com/en/our-commitment-to-transparency]. Accessed 15 April 2016. UR - http://www.shiretrials.com/en/our-commitment-to-transparency ID - ref40 ER - TY - STD TI - Bristol-Myers Squibb. Disclosure commitment. [http://bms.com/clinical_trials/pages/disclosure.aspx]. Accessed 15 April 2016. UR - http://bms.com/clinical_trials/pages/disclosure.aspx ID - ref41 ER - TY - STD TI - Clinical Data Interchange Standards Consortium. CDISC mission and principles. [http://www.cdisc.org/CDISC-Vision-and-Mission]. Accessed 15 April 2016. UR - http://www.cdisc.org/CDISC-Vision-and-Mission ID - ref42 ER - TY - STD TI - Dugas M, Jöckel K-H, Friede T, Gefeller O, Kieser M, Marschollek M, Ammenwerth E, Röhrig R, Knaup-Gregori P, Prokosch H-U. Memorandum “Open Metadata”: Open access to documentation forms and item catalogs in healthcare. Methods Inform Med. 54: 376–8. doi: 10.3414/ME15-05-0007. [http://www.ncbi.nlm.nih.gov/pubmed/26108979]. UR - http://www.ncbi.nlm.nih.gov/pubmed/26108979 ID - ref43 ER - TY - JOUR AU - Hrynaszkiewicz, I. AU - Norton, M. AU - Vickers, A. AU - Altman, D. PY - 2010 DA - 2010// TI - Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c181 DO - 10.1136/bmj.c181 ID - Hrynaszkiewicz2010 ER - TY - JOUR AU - Hughes, S. AU - Wells, K. AU - McSorley, P. AU - Freeman, A. PY - 2014 DA - 2014// TI - Preparing individual patient data for clinical trials for sharing: the GlaxoSmithKline approach JO - Pharm Stat VL - 13 UR - https://doi.org/10.1002/pst.1615 DO - 10.1002/pst.1615 ID - Hughes2014 ER - TY - STD TI - TransCelerate Biopharma Inc. Data de-identification and anonymization of individual patient data in clinical studies – a model approach. [http://www.transceleratebiopharmainc.com/wp-content/uploads/2015/04/Data-Anonymization-Paper-FINAL-5.18.15.pdf] Accessed 16 April 2016. UR - http://www.transceleratebiopharmainc.com/wp-content/uploads/2015/04/Data-Anonymization-Paper-FINAL-5.18.15.pdf ID - ref46 ER - TY - STD TI - Tucker K, Branson J, Dilleen M, Hollis S, Loughlin P, Dixon MJ, Williams Z. Protecting patient privacy when sharing patient-level data from clinical trials. BMC Med Res Methodol. 2016 (accepted for publication). ID - ref47 ER -